Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 10/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 10/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6209359 | 0.98 | LMNA (0.51) | LMNAALDH1A1SMN1; SMN2L3MBTL1POLB | |
| SCHEMBL6492041 | 0.81 | SLC6A4 (0.68) | LMNASMN1; SMN2L3MBTL1SLC6A4SLC6A3 | |
| SCHEMBL6240339 | 0.80 | SLC6A3 (0.60) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL6208716 | 0.79 | SLC6A4 (0.65) | LMNAALDH1A1SMN1; SMN2L3MBTL1POLB | |
| SCHEMBL7573036 | 0.78 | SOAT2 (0.51) | LMNAALDH1A1SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL6209826 | 0.78 | SLC6A3 (0.58) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL6494934 | 0.76 | SLC6A4 (0.63) | LMNASLC6A4SLC6A3SLC6A2 | |
| SCHEMBL6231738 | 0.74 | SLC6A3 (0.61) | LMNASLC6A4SLC6A3SLC6A2 | |
| SCHEMBL16823453 | 0.74 | SLC6A4 (0.62) | LMNAALDH1A1SMN1; SMN2L3MBTL1POLB | |
| SCHEMBL6209698 | 0.73 | RORC (0.47) | LMNASLC6A4SLC6A3SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11229590-B2 | Sunscreen formulation | SUN YIMIN (CN) | 2022-01-25 | — | — | US | disclosed |
| US-20210361548-A1 | A SUNSCREEN FORMULATION | SUN YIMIN (CN) | 2021-11-25 | — | — | US | disclosed |
| US-20050234096-A1 | Tetrahydroisoquinoline derivatives | BAYER HEALTHCARE AG (DE) | 2005-10-20 | — | — | US | disclosed |
| US-20050154042-A1 | N-alkyl pyrroles as HMG-CoA reductase inhibitors | WARNER-LAMBERT COMPANY | 2005-07-14 | — | — | US | disclosed |
| EP-1507763-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | Bayer HealthCare AG (DE) | 2005-02-23 | — | — | EP | disclosed |
| WO-2003097607-A1 | TETRAHYDROISOQUINOLINE DERIVATIVES | BAYER HEALTHCARE AG (DE) | 2003-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210361548-A1 | A SUNSCREEN FORMULATION | CUTA, BCAS2, SUN2 | LMNA 1634/4885ALDH1A1 598/4885SMN1; SMN2 2909/4885 |
| US-11229590-B2 | Sunscreen formulation | BCAS2, CUTA, SUN2 | LMNA 1586/4885ALDH1A1 685/4885SMN1; SMN2 2747/4885 |
| US-20050154042-A1 | N-alkyl pyrroles as HMG-CoA reductase inhibitors | HMGCR, DHCR7, CYP11A1 | LMNA 657/4885ALDH1A1 1452/4885SMN1; SMN2 4781/4885 |
| US-20050234096-A1 | Tetrahydroisoquinoline derivatives | PPARD, PPARG, PPARA | LMNA 2034/4885ALDH1A1 2218/4885SMN1; SMN2 4874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.